Assesses annual fees on animal drug products, establishments, and sponsors.
Establishes a fee schedule for FY 2003 through 2007, including total fee revenues for animal drug products, establishments, and sponsors. Adjusts fees to reflect inflation, review workload, operating reserves of carryover user fees (in the final year), and to maintain an equal balance of revenue from applications, products, establishments, and sponsors. Reduces or waives fees: (1) in excess of administrative costs; (2) that present a significant barrier to innovation; (3) to promote availability for minor uses or use in minor species; or (4) for first applications by a small business.
Makes fees available for obligation only to the extent provided in advance in appropriations Acts. Offsets any excess fees against subsequent appropriations.